TIDMSPSY TIDMSPSC

RNS Number : 4387N

Spectra Systems Corporation

25 September 2023

Spectra Systems Corporation

Interim Results for the Six Months Ended 30 June 2023

Spectra Systems Corporation ("Spectra Systems" or the "Company"), a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, is pleased to announce its interim results for the six months ended 30 June 2023.

Financial highlights:

   --    Revenue of $11,621k (2022: $9,265k) up 25% 
   --    Adjusted EBITDA(1)  up 55% at $5,903k (2022: $3,818k) 
   --    Adjusted PBTA(1)  up 59% to $5,837k (2022: $3,669k) 
   --    Adjusted earnings(2)  per share up 74% to US $10.8 cents (2022: US $6.2 cents) 
   --    Cash generated from operations of $4,418k (2022: $7,245k) 
   --    Strong, debt-free balance sheet, with cash(3)  of $16,582k (2022: $17,961k) at 30 June 2023 

(1) Before stock compensation expense and excludes non-controlling interest

(2) Before amortization and stock compensation expense, excludes noncontrolling interest and fewer remaining tax credits

(3) Does not include $500,000 (2022: $500,000) of restricted cash and investments

Operational highlights:

-- Achieved key development and payment milestones for sensor development program positioning Spectra Systems for preproduction units in 2024 and production units in 2025

-- Completed fiscal year order at 22% higher pricing with in-house manufacturing for supply chain mitigation with a major central bank customer

   --    Ongoing large print trial of polymer substrate with Middle Eastern central bank 
   --    Successful tests with new K-cup printer completed 

-- Successful installation and staff training for our first Banknote Disinfection System with an Asian central bank

   --    Hired new managing director for Canadian gaming software division 

Commenting on the results, Nabil Lawandy, Chief Executive Officer, said:

"The Company's first half revenues and earnings are up substantially from the six months ended June 30, 2022 with increases of 25% and 59% for revenue and PBTA, respectively. Our cash position remains strong at $16,582k with a debt free balance sheet. The increased revenues in the first half are derived principally from pre-production development contracts as well as larger demand for our materials to meet increased banknote demands of one of our existing central bank customers.

We have achieved key milestones with our sensor development contract and are moving into the final phase of the program with the delivery of preproduction units in Q4 of 2024. The central bank customer expects to provide a first draft of the manufacturing contract in H2 of this year.

Our anticipation of potential supply chain issues and proactive implementation of a supply chain mitigation program with our largest central bank customer has resulted in significantly enhanced revenues in H1 as we have been able to complete that entire fiscal year order for 2022-2023 on time.

On the optical materials front, we have significantly grown revenue from K-cup printers and have received approval from a third customer in Canada which we expect to place a first order in Q1 of 2024.

With regards to our suite of smartphone-based authentication solutions, we have initiated a testing program with a UK passport company and are awaiting approval on the use of our combined smartphone and covert authentication holographic labels for protection of physical versions of non-fungible token ("NFT") artwork

Finally, our gaming software operation has gone live with the New York State lottery, and we have appointed a new managing director with a strong background in software management, development and sales.

"The Board therefore believes that the Company is on track to achieve record earnings and meet market expectations for the full year."

 
     Spectra Systems Corporation                               Tel: +1 (0)401 274 4700 
      Dr. Nabil Lawandy, Chief Executive Officer 
     WH Ireland Limited (Nominated Adviser and                 Tel: +44 (0)20 7220 1650 
      Joint Broker) 
      Chris Fielding/James Bavister (Corporate 
      Finance)                                                  Tel: +44 (0)20 3328 5665 
      Fraser Marshall (Corporate Broking) 
 
      Allenby Capital Limited (Joint Broker) 
      Nick Naylor/James Reeve (Corporate Finance) 
      Amrit Nahal/Guy McDougall (Sales and Corporate 
      Broking) 
 
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The person responsible for arranging the release of this announcement on behalf of the Company is Dr. Nabil Lawandy, Chief Executive of the Company.

Chief Executive Officer's statement

Introduction

In H1 2023, we have already achieved a PBTA level which is 73% of the market expectations for the year. We are therefore highly confident we will achieve market expectations for the full year.

Revenue was up 25% at $11,621k (2022: $9,265k) for the first half of the year. The increased revenues in the first half are derived principally from pre-production development contracts, as well as strong demand for our materials to meet the banknote requirements of one of our existing central bank customers.

As a result of the increased revenue, adjusted EBITDA (before stock compensation expense) for the half year increased 55% to $5,903k compared to the prior year of $3,818k.

Having generated cash from operations of $4,418k (2022: $7,245k), cash at the period end amounted to $16,582k (2022: $17,961k), excluding $500,000 of restricted cash and investments (2022: $500k). This is notwithstanding $5,102k paid to shareholders during June in the form of the Company's annual dividend of $0.115.

Review of Operations

Physical and Software Authentication Business

The Authentication Systems business generated revenue of $10,589k (2022: $8,565k) and Adjusted EBITDA of $4,698k (2022: $3,878k).

Authentication Systems revenues are driven by sales of covert materials and their associated equipment and service, optical and security phosphor materials, and the final license payments from our licensee. The increased revenue is due to a combination of sizable materials orders and meeting several key payment milestones relating to sensor development funding from our long-standing central bank customer. We continue to move forward with this central bank towards the delivery of the preproduction sensors in late 2024. In addition, we have executed a $1.9mm contract with a central bank customer for Quality control equipment in H1 which will impact our revenue and PBTA primarily in 2024-2025.

Through our strong partnership with Cartor Security Printers in Wolverhampton we have further refined our abilities and yields of high quality conducting and opacified polymer substrates for evaluation by central banks, ink suppliers and printing organizations. We have produced custom designed sheets for a Middle Eastern central bank to be used in large scale print trials which continue. Final decisions have been delayed as the central bank has had to deal with local hyperinflation and has shifted temporarily to the printing of paper substrate notes in other denominations.

In addition, the Company has formed a close working relationship with the largest commercial printer of polymer banknotes and is near completion of a house note which will incorporate both our FusionTM machine readable security as well as their newest public security feature. The Directors anticipate that the result of this joint development will be polymer banknotes of the highest quality for a joint marketing effort.

During H1 and going forward, we are utilizing our increased profitability to further support sales and marketing efforts. Since recruiting an experienced sales director for banknote technology in December of 2022, we have forged relationships with a number of central banks for our polymer product as well as other related authentication technology. With this additional recruitment, we have been able to free up time from our existing staff to further increase our sales efforts in brand authentication as well as document security, with a focus on passports.

The smartphone technology has been seeded in Asia for cigarettes and stationery for some time and while this continues to percolate, we have opened new opportunities in the NFT art and passport data page security areas. We now have a revised target of $1mm of revenues for this technology by close of 2024.

Our K-cup materials business has grown significantly since a new customer began purchasing our products in H2 2021. We have recently successfully completed trials with a Canadian printer of K-cups and are currently working on assessing the additional revenue with this customer for 2024; we are hopeful we may begin filling orders in H2.

On the software security side of the Company's business, the Secure Transactions Group, formed around two gaming technology acquisitions made in 2012, generated an Adjusted EBITDA of $40k (2022:($60k)) on revenue of $840k (2022: $700k). The H1 results are in line with expectations for this first half of the year and we expect an increase in H2 with several lottery wins from last year going live.

Banknote Cleaning and Disinfection Business

In 2022, we sold our first Banknote Disinfection System (BDS) for use by an Asian central bank. During H1 2023, we have successfully installed the BDS and trained the central bank staff. With this first unit now installed and operational, we are able to provide a full reference for other central banks.

Strategy

The Company's strategy for increasing revenue and earnings continues to be focused on selling more products to existing customers as well as opening new sales channels for the full spectrum of our product offerings.

We have had very good success in upselling existing central bank customers and commercially exploiting supply chain and pandemic related issues as part of our strategy. Examples of these successes are the expansion of sensor capabilities for exotic counterfeits, the development and first sale of a banknote disinfection machine, and the commencement of a program with our customer to deal with supply chain issues now and going forward.

Our strategy for growing our newest and potentially transformative technology for polymer banknotes is based on validation, followed by a commemorative banknote contract and then a full banknote denomination contract. The validation is focused on three major stakeholders in the polymer banknote industry: the ink manufacturers, the commercial printers, and the state printworks. Our primary targets are central banks which are currently using paper substrates and are contemplating a transition to polymer, as well as central banks who have decided not to use polymer for higher denominations due to security concerns.

With regards to our optical materials and brand authentication products, we continue to propose to both central banks and overt security suppliers the concept of upgrading security features to incorporate public and machine-readable security. The strategy behind this approach is based around partnering with suppliers who can benefit from our technology and materials to upsell their existing customers.

Finally, we continue to explore strategic as well as increased sales channel-based mergers and acquisitions. The active search for such opportunities is being accelerated as we expect to have significant cash resources through the successful delivery of the major central bank sensor contract.

Prospects

The Company has several new sales opportunities which mirror the broad-spectrum of products we have developed. The inventiveness which we have demonstrated repeatedly is a key component of our growth strategy and drives our profit generation process strategy. This approach has led to a high margin, intellectually driven, patent protected suite of products from products from smartphone authentication, to viral disinfection of banknotes to cutting-edge covert technologies.

Opportunities within the next 24 months or less include:

   --    Completion of sensor development and revenue recognition of the remaining 

sensor development payments

-- Completion, delivery, and payment for a new online Quality Control system contract received this year

   --    First sensor shipments to a central bank commencing in Q2 2025 
   --    Sale of additional Banknote Disinfection Systems 
   --    Increased sales of our optical materials for K-cups and phosphor applications 
   --    Expansion of our gaming software business in Canada and in the online lottery market 

Opportunities within the next 3-5 years:

   --    TruBrandTM for use in art protection and passport data pages 
   --    A commemorative note series using our Fusion polymer substrate 
   --    Supply of upgraded sensors worth up to $50mm in hardware to a central bank customer 

-- Supply of FusionTM polymer substrate and sensors to a central bank for one or more banknote denominations

-- Significantly increased adoption of covert authentication materials by a current or new central bank customer

The combination of these prospects, both short and long-term, has positioned the Company to continue its revenue and earnings growth over the coming years. We continue to develop cutting edge technologies to remain the technology leader in the authentication industry and to offer our shareholders growth through innovation for both new and existing customers.

Nabil M. Lawandy

Chief Executive Officer

September 25, 2023

Consolidated statements of income

for the half year ended 30 June 2023

 
                                       Half Year                    Half Year                    Full Year 
                                       to 30 Jun                    to 30 Jun                    to 31 Dec 
                                          2023                         2022                         2022 
                                       Unaudited                    Unaudited                     Audited 
                                        USD '000                     USD '000                    USD '000 
     Revenues 
       Product                   $ 7,242                      $ 5,488                      $ 11,208 
       Service                                 3,945                        2,907                        6,681 
       License and royalty                        434                          870                       1,738 
                            ---------------------------  ---------------------------  -------------------------- 
     Total revenues                          11,621                         9,265                      19,627 
 
     Cost of sales                             3,581                        3,145                        7,351 
                            ---------------------------  ---------------------------  -------------------------- 
 
       Gross profit                            8,040                        6,120                      12,276 
 
     Operating expenses 
       Research and 
        development                               702                          837                       1,507 
       General and 
        administrative                         1,577                        1,481                        3,023 
       Sales and marketing                        415                          478                          753 
                            ---------------------------  ---------------------------  -------------------------- 
     Total operating 
      expenses                                 2,694                        2,796                        5,283 
                            ---------------------------  ---------------------------  -------------------------- 
 
       Operating profit                        5,346                        3,324                        6,993 
 
     Interest and other 
      income                                      172                              8                         17 
     Loss on sale of                                  -                            -        - 
     equipment 
     Foreign currency 
      gain(loss)                                  (35)                             3                         (8) 
                            ---------------------------  ---------------------------  -------------------------- 
 
       Profit before taxes                     5,483                        3,335                        7,002 
 
     Income tax expense                          784                           707                          901 
                            ---------------------------  ---------------------------  -------------------------- 
 
       Net income                              4,699                        2,628                        6,101 
 
     Net income (loss) 
      attributable 
      to noncontrolling 
      interest                     14                           22                           46 
                            ---------------------------  ---------------------------  -------------------------- 
 
     Net income 
      attributable 
      to Spectra Systems 
      Corporation                  $ 4,713                      $ 2,650                      $ 6,147 
                            ===========================  ===========================  ========================== 
 
     Earnings per share 
       Basic                     $ 0.10                       $ 0.06                       $ 0.14 
       Diluted                   $ 0.10                       $ 0.06                       $ 0.13 
 
 

Consolidated statements of comprehensive income

for the half year ended 30 June 2023

 
                                              Half Year                 Half Year                 Full Year 
                                              to 30 Jun                 to 30 Jun                 to 31 Dec 
                                                 2023                      2022                      2022 
                                              Unaudited                 Unaudited                  Audited 
                                              USD '000                  USD '000                  USD '000 
 
     Net income                          $ 4,713                   $ 2,628                   $ 6,101 
 
       Other comprehensive 
       income (loss) 
     Unrealized gain (loss) 
      on currency exchange                 (45)                      1                         (45) 
     Reclassification for 
      realized (gain) loss 
      in net income                        35                        (3)                       8 
                                    ------------------------  ------------------------  ------------------------ 
 
       Total other comprehensive 
        loss                               (10)                      (2)                       (37) 
                                    ------------------------  ------------------------  ------------------------ 
 
     Comprehensive income                              4,703                     2,626                     6,064 
 
     Net gain (loss) attributable 
      to noncontrolling interest           14                        22                        (46) 
                                    ------------------------  ------------------------  ------------------------ 
 
     Comprehensive income 
      attributable to Spectra 
      Systems Corporation                $ 4,717                   $ 2,648                   $ 6,018 
 
 
 
 

Consolidated balance sheets

as of 30 June 2023

 
                                                      As of                   As of                    As of 
                                                   30 Jun 2023             30 Jun 2022              31 Dec 2022 
                                                    Unaudited               Unaudited                 Audited 
                                                    USD '000                 USD '000                USD '000 
     Current assets 
     Cash and cash equivalents                  $ 16,582                $ 17,961                 $ 17,496 
     Trade receivables, net of allowance                   3,095                   1,384                    3,677 
     Unbilled and other receivables                        1,002                      527                   1,133 
     Inventory                                             2,368                   2,192                    1,599 
     Prepaid expenses                                         795                  1,272                       760 
                                                                   ----------------------- 
       Total current assets                              23,842                  23,336                   24,665 
 
     Non-current assets 
     Property, plant and equipment, net                    1,910                   1,617                    2,102 
     Operating lease right of use assets, 
      net                                                  1,659                      828                   1,217 
     Intangible assets, net                                6,970                   7,057                    7,055 
     Restricted cash and investments                          500                     500                      500 
     Deferred tax assets                                   1,848                      530                   1,881 
     Other assets                                             595                     105                      597 
                                           ----------------------  -----------------------  ---------------------- 
       Total non-current assets                          13,482                  10,637                   13,352 
 
       Total assets                             $ 37,324                $ 33,973                 $ 38,017 
                                           ======================                           ====================== 
 
     Current liabilities 
     Accounts payable                           $ 796                   $ 664                    $ 929 
     Accrued expenses and other 
      liabilities                                             476                     465                      504 
     Operating lease liabilities, short 
      term                                                    392                     289                      298 
     Taxes payable                                            194                       49                     684 
     Deferred revenue                                      4,601                   1,898                    4,626 
                                           ----------------------  -----------------------  ---------------------- 
       Total current liabilities                           6,459                   3,365                    7,041 
 
     Non-current liabilities 
     Operating lease liabilities, long 
      term                                                 1,319                      595                      975 
     Deferred revenue                                      1,590                   4,968                    1,679 
                                           ----------------------  -----------------------  ---------------------- 
       Total non-current liabilities                       2,909                   5,563                    2,654 
 
       Total liabilities                                   9,368                   8,928                    9,695 
                                           ----------------------  -----------------------  ---------------------- 
 
     Stockholders' equity 
     Common stock                                            450                     451                      450 
     Additional paid in capital - common 
      stock                                             53,270                  53,336                   53,178 
     Accumulated other comprehensive loss                  (186)                   (138)                     (174) 
     Accumulated deficit                              (26,319)                (29,224)                  (25,727) 
                                                                   ----------------------- 
       Total Spectra Systems Corporation 
        stockholders' equity                      27,215                  24,425                   27,727 
     Noncontrolling interest                                 741                     620                      595 
                                           ----------------------  -----------------------  ---------------------- 
       Total stockholders' equity               ` 27,956                        25,045                   27,921 
                                           ----------------------  -----------------------  ---------------------- 
 
       Total liabilities and 
        stockholders' equity                    $ 37,324                $ 33,973                 $ 38,017 
                                           ======================                           ====================== 
 

Consolidated statements of cash flows

for the half year ended 30 June 2023

 
                                        Half Year                    Half Year                    Full Year 
                                        to 30 Jun                    to 30 Jun                    to 31 Dec 
                                           2023                         2022                         2022 
                                        Unaudited                    Unaudited                     Audited 
                                         USD '000                     USD '000                     USD '000 
     Cash flows from 
     operating 
     activities 
     Net income                   $ 4,699                      $ 2,628                      $ 6,101 
     Adjustments to 
     reconcile net 
     income to net cash 
     provided 
     by operating 
     activities 
       Depreciation and 
        amortization                              459                          418                           917 
       Stock based 
        compensation 
        expense                                     92                           65                          142 
       Lease amortization 
        expense                                     89                         142                           287 
       Deferred taxes                                32                        550                         (801) 
       Allowance for 
        doubtful accounts                             -                            -                           (4) 
       Provision for excess 
        and obsolete 
        inventory                               -                                  -                         694 
       Loss on sale of                                -                            -                           - 
       equipment 
       Changes in operating 
       assets 
       and liabilities 
         Accounts 
          receivables                             581                          861                      (1,428) 
         Unbilled and other 
          receivables                             131                          102                          (503) 
         Inventory                               (770)                        (248)                        (349) 
         Prepaid expenses                          (34)                       (974)                        (463) 
         Other assets                                 -                            -                       (500) 
         Accounts payable                        (133)                         175                           441 
         Operating leases                          (92)                       (140)                         (285) 
         Accrued expenses 
          and other 
          liabilities                            (518)                        (262)                          417 
         Deferred revenue                        (118)                      3,928                         3,374 
                             ---------------------------  ---------------------------  --------------------------- 
     Net cash provided by 
      operating 
      activities                                4,418                       7,245                         8,040 
 
     Cash flows from 
     investing 
     activities 
     Restricted cash and                             (3)                            -                            - 
     investments 
     Payment of patent and 
      trademark 
      costs                                      (129)                        (147)                        (476) 
     Proceeds from sale of                             -                            -                            - 
     equipment 
     Purchases of property, 
      plant 
      and equipment                                  (8)                      (338)                        (988) 
                             ---------------------------  ---------------------------  --------------------------- 
     Net cash provided by 
      (used 
      in) investing 
      activities                                 (140)                        (485)                     (1,464) 
 
     Cash flows from 
     financing 
     activities 
     Dividends paid                           (5,182)                      (5,004)                      (5,004) 
     Repurchase of shares                             -                       (570)                        (807) 
     Proceeds from exercise 
      of stock 
      options                                         -                            6                            6 
                             ---------------------------  ---------------------------  --------------------------- 
     Net cash used in 
      financing 
      activities                              (5,182)                      (5,568)                      (5,805) 
 
     Effect of exchange 
      rate on 
      cash and cash 
      equivalents                   (10)                         (6)                          (50) 
                             ---------------------------  ---------------------------  --------------------------- 
 
     Net increase(decrease) 
      in 
      cash and cash 
      equivalents                                (914)                     (1,186)                        721 
     Cash and cash 
      equivalents 
      , beginning of period         17,496                       16,775                       16,775 
                             ---------------------------  ---------------------------  --------------------------- 
     Cash and cash 
      equivalents 
      , end of period             $ 16,582                     $ 17,961                     $ 17,496 
                             ===========================  ===========================  =========================== 
 

Notes to financial information

1. Basis of preparation

This report was approved by the Directors on the 18 September 2023.

This financial information has been prepared using the recognition and measurement principles of US Generally Accepted Accounting Principles (GAAP). The Group has not elected to apply IAS 34 Interim Financial Reporting.

The principal accounting policies used in preparing the interim results are those the Company expects to apply in its financial statements for the year ending 31 December 2023 and are unchanged from those disclosed in the Company's Annual Report for the year ended 31 December 2022.

The results for the half year are unaudited. The financial information for the year ended 31 December 2022 does not constitute the full statutory accounts for that period. The Annual Report and financial statements for the year ended 31 December 2022 have been filed with the Registrar of Companies. The Independent Auditors' Report on the financial statements for the year ended 31 December 2022 was unmodified and did not draw attention to any matters by way of emphasis.

2. Earnings per share

The calculation of basic earnings per share is based on the net income divided by the weighted average number of common shares outstanding. Diluted earnings per share is calculated by considering the dilutive impact of common stock equivalents under the treasury stock method as if they were converted into common stock as of the beginning of the period or as of the date of grant, if later. Excluded from the calculation of diluted earnings per common share for the six months ended June 30, 2023, and the year ended December 31, 2022, were 189,000 and 186,773 shares related to stock options, respectively, because their exercise prices would render them anti-dilutive. For the six months ended June 30, 2022,159,845 were excluded from the calculation of diluted earnings per common share. The following table shows the calculation of basic and diluted earnings per common share .

 
                                                  Half Year              Half Year              Full Year 
                                                  to 30 Jun              to 30 Jun              to 31 Dec 
                                                     2023                   2022                   2022 
     Numerator: 
      Net income                               $ 4,712,975            $ 2,650,000            $ 6,147,374 
 
     Denominator: 
      Weighted average common 
       shares                                       45,143,754             45,569,258             45,189,208 
         Effect of dilutive securities: 
           Stock Options                              1,957,249              2,233,298              2,132,610 
                                          ---------------------  ---------------------  --------------------- 
      Diluted weighted average 
       common shares                             47,101,003             47,802,556             47,321,818 
                                          =====================  =====================  ===================== 
 
     Earnings per common share: 
       Basic:                                  $ 0.10                 $ 0.06                 $ 0.14 
                                          =====================  =====================  ===================== 
       Diluted:                                $ 0.10                 $ 0.06                 $ 0.13 
                                          =====================  =====================  ===================== 
 

3. Investment in affiliates and other entities

During the course of business, the Company enters into various types of investment arrangements. The Company determines whether such investments involve variable interest entities (VIEs). If the entity is determined to be a VIE, then management determines if the Company is the primary beneficiary of the entity and whether or not consolidation of the VIE is required. The primary beneficiary consolidating the VIE must normally have both (i) the power to direct the activities of a VIE that most significantly affect the VIE's economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE, in either case that could potentially be significant to the VIE. When the Company is deemed to be the primary beneficiary, the VIE is consolidated and the other party's equity interest in the VIE is accounted for as a noncontrolling interest.

On December 10, 2020, the Company invested $702,000 in Solaris BioSciences ("Solaris") and increased its equity interest from 4.79% to 48.65% on an as converted basis. A noncontrolling interest is attributable to the 51.35% of Solaris not owned by the Company. Prior to the investment, the Chief Executive Officer of Spectra owned 84.54% of Solaris which declined to 46.01% after the transaction. As part of the transaction, the Company committed to provide $100,000 of services at cost to Solaris, of which $93,558 were provided during the six months ended June 30, 2021. In addition, the Company will provide nominal accounting support to Solaris and allow Solaris use of optical table space and facilities at Spectra. In accordance with Delaware law, the transaction was (a) unanimously approved by all three of Spectra's non-executive Directors and (b) specially approved by a majority-in-interest of the disinterested stockholders of Solaris. In addition, going forward Spectra's shares in Solaris will be voted as directed by Spectra's non-executive Directors. The Chief Executive Officer of Solaris is also the Chief Executive Officer of Spectra.

The Company has concluded that Solaris is a VIE and the Company is the primary beneficiary. The Company has consolidated the accounts of Solaris as of December 10, 2020. The aggregate carrying value of Solaris' assets and liabilities after elimination of any intercompany transactions and balances in the consolidated balance sheets were as follows:

 
                                                  As of                     As of                     As of 
                                               30 Jun 2023               30 Jun 2022               31 Dec 2022 
                                                Unaudited                 Unaudited                  Audited 
                                                USD '000                  USD '000                  USD '000 
     Assets 
      Cash                                 $ 14                      $ 101                     $ 150 
      Property, plant and equipment, 
       net                                                   7                         7                         8 
      Intangible assets, net                             110                         56                        40 
                                      ------------------------  ------------------------  ------------------------ 
     Total Assets                                        131                       164                       197 
 
     Liabilities 
      Accounts payable                                     22                          -                       21 
      Accrued expenses and other                             -                         -                         - 
      liabilities 
     Total liabilities                     $ 22                      $ -                       $ 21 
 

4. Copies of this statement are available to the public on the Company's website at http://www.spsy.com.

Appendix - Reconciliation of Non-GAAP measures

The Company publishes certain additional information in a non-statutory format in order to provide readers with an increased insight into the underlying performance of the business. Reconciliations to the GAAP measures are shown in the following tables:

 
       Half Year         Half Year         Full Year 
       to 30 Jun         to 30 Jun         to 31 Dec 
          2023              2022              2022 
       Unaudited         Unaudited         Unaudited 
       USD '000          USD '000          USD '000 
 

Adjusted earnings before interest, taxes,

depreciation and amortization (EBITDA)

 
     Operating profit                 $ 5,346                    $ 3,324                     $ 6,993 
     Depreciation                                     203                         159                         321 
     Amortization                                     254                         257                         594 
     Stock compensation                                92                           65                        142 
     Operating loss - 
      noncontrolling 
      interest                                          13                          22                          46 
     Stock compensation - 
      noncontrolling 
      interest                                         (5)                        (10)                        (19) 
       Adjusted EBITDA                $ 5,903                    $ 3,817                     $ 8,077 
 

Adjusted profit before taxes and

amortization (PBTA)

 
     Profit before taxes               $ 5,483                   $ 3,335                     $ 7,002 
     Amortization                                     254                         257                         594 
     Stock compensation                                 92                          65                        142 
     Operating loss - 
      noncontrolling 
      interest                                          13                          22                          46 
     Stock compensation - 
      noncontrolling 
      interest                                         (5)                        (10)                        (19) 
       Adjusted PBTA                   $ 5,837                   $ 3,669                     $ 7,765 
 

Adjusted earnings per share

 
     Adjusted PBTA                      $ 5,837                    $ 3,669                    $ 7,765 
     Income tax expense                                (784)                      (707)                      (901) 
       Adjusted earnings                $ 5,053                    $ 2,962                    $ 6,864 
 
     Diluted weighted average 
      common 
      shares                                 47,101,003                 47,802,556                 47,321,818 
 
       Adjusted earnings per 
        share                           $ 0.108                    $ 0.062                    $ 0.145 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IR FLFFEAIISFIV

(END) Dow Jones Newswires

September 25, 2023 02:00 ET (06:00 GMT)

Spectra Systems (LSE:SPSY)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Spectra Systems.
Spectra Systems (LSE:SPSY)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Spectra Systems.